Trial intelligence / Profile preview

ACTION: Anakinra in Intracerebral Haemorrhage

NCT04834388Phase 2Recruiting

Sponsor
Radboud University Medical Center
Start
Aug 2022
Primary completion
Sep 2025
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in intracerebral hemorrhage (ICH), sponsored by Radboud University Medical Center. Started Aug 2022; status: recruiting.

02

Drugs

anakinra
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on NCT04834388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04834388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call